| Primary |
| Prostate Cancer |
52.5% |
| Breast Cancer |
13.6% |
| Hypertension |
7.9% |
| Endometriosis |
6.3% |
| Uterine Leiomyoma |
2.1% |
| Pain |
1.8% |
| Insomnia |
1.8% |
| Benign Prostatic Hyperplasia |
1.5% |
| Diabetes Mellitus |
1.4% |
| Gastritis |
1.3% |
| Gastritis Atrophic |
1.3% |
| Asthma |
1.2% |
| Depression |
1.2% |
| Breast Cancer Female |
1.1% |
| Conjunctivitis Allergic |
1.0% |
| Constipation |
1.0% |
| Hyperlipidaemia |
0.9% |
| Lumbar Spinal Stenosis |
0.9% |
| Cardiac Failure |
0.7% |
| Hyperuricaemia |
0.7% |
|
| Death |
28.5% |
| Interstitial Lung Disease |
15.6% |
| Weight Increased |
11.4% |
| Prostatic Specific Antigen Increased |
5.1% |
| Vomiting |
4.4% |
| Hot Flush |
3.4% |
| Prostate Cancer |
3.4% |
| Myocardial Infarction |
3.2% |
| Weight Decreased |
3.2% |
| Hepatic Function Abnormal |
2.1% |
| Malaise |
2.1% |
| Malignant Neoplasm Progression |
2.1% |
| Neoplasm Malignant |
2.1% |
| Psychotic Disorder |
2.1% |
| Cerebrovascular Accident |
1.9% |
| Deep Vein Thrombosis |
1.9% |
| Injection Site Haematoma |
1.9% |
| Injection Site Haemorrhage |
1.9% |
| Liver Function Test Abnormal |
1.9% |
| White Blood Cell Count Decreased |
1.9% |
|
| Secondary |
| Prostate Cancer |
49.2% |
| Breast Cancer |
17.2% |
| Product Used For Unknown Indication |
5.7% |
| Hypertension |
4.6% |
| Breast Cancer Metastatic |
4.1% |
| Insomnia |
2.5% |
| Diabetes Mellitus |
2.5% |
| Her-2 Positive Breast Cancer |
2.0% |
| Endometriosis |
1.7% |
| Pain |
1.6% |
| Uterine Leiomyoma |
1.4% |
| Drug Use For Unknown Indication |
1.1% |
| Vaginal Haemorrhage |
0.9% |
| Benign Prostatic Hyperplasia |
0.8% |
| Bone Disorder |
0.8% |
| Anaemia |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Glaucoma |
0.8% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Reflux Oesophagitis |
0.7% |
|
| Weight Increased |
13.0% |
| Vomiting |
6.9% |
| Malignant Neoplasm Progression |
6.5% |
| Cerebral Infarction |
5.1% |
| Hypokalaemia |
5.1% |
| Interstitial Lung Disease |
5.1% |
| Pain |
5.1% |
| White Blood Cell Disorder |
5.1% |
| Liver Disorder |
4.6% |
| Platelet Count Decreased |
4.6% |
| Renal Impairment |
4.6% |
| Diabetes Mellitus |
4.2% |
| Neoplasm Progression |
4.2% |
| Orthostatic Hypotension |
4.2% |
| Surgery |
4.2% |
| Hepatic Function Abnormal |
3.7% |
| Pleural Effusion |
3.7% |
| Thrombocytopenia |
3.7% |
| Death |
3.2% |
| Disease Progression |
3.2% |
|
| Concomitant |
| Prostate Cancer |
26.5% |
| Prostate Cancer Metastatic |
10.6% |
| Breast Cancer |
10.2% |
| Metastases To Bone |
8.7% |
| Product Used For Unknown Indication |
7.7% |
| Hypertension |
6.6% |
| Pain |
4.9% |
| Drug Use For Unknown Indication |
4.5% |
| Prophylaxis |
3.4% |
| Depression |
2.7% |
| Hormone Therapy |
2.4% |
| Breast Cancer Metastatic |
2.0% |
| Nausea |
1.6% |
| Diabetes Mellitus |
1.5% |
| Bone Pain |
1.2% |
| Constipation |
1.2% |
| Osteoporosis |
1.2% |
| Anaemia |
1.1% |
| Drug Therapy |
1.0% |
| General Physical Condition |
1.0% |
|
| Vomiting |
12.7% |
| Weight Decreased |
12.7% |
| Tooth Extraction |
9.4% |
| Osteonecrosis |
5.3% |
| Pyrexia |
5.3% |
| Death |
4.9% |
| Prostatic Specific Antigen Increased |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| Swelling |
4.5% |
| Toothache |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Pneumonia |
3.6% |
| Prostate Cancer |
3.6% |
| Osteonecrosis Of Jaw |
3.3% |
| Pulmonary Embolism |
3.3% |
| Dyspnoea |
2.9% |
| Malaise |
2.9% |
| Wound Infection Staphylococcal |
2.9% |
| Cerebral Ischaemia |
2.7% |
| Renal Failure Acute |
2.7% |
|
| Interacting |
| Hormone Therapy |
63.6% |
| Prostate Cancer |
22.7% |
| Immunosuppressant Drug Therapy |
13.6% |
|
| Drug Interaction |
75.0% |
| Ventricular Extrasystoles |
25.0% |
|
